SLVM
Sylvamo Corporation51.31
-0.14-0.27%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Europe ops color, lean launch detailed
Q&A spotlighted Europe's gritty recovery, with Säffle mill's Q4 investment boosting roll orders yet Sims warning current margins are unsustainable without Q2 price realization and easing Swedish wood costs. Management detailed a lean overhaul launching in Latin America—its past success story—to double improvement rates and sharpen customer focus, alongside digital efforts eyed at Investor Day. Buybacks paused in Q4 to fund 2026's $245M capex and $95M transition hits, after lapping 350% of FCF returns. Nymölla fits long-term but faces options review, including pulp buys. Analysts pressed on guidance suspension; team doubled down on long-term alignment. Lean traction matters next.
Key Stats
Market Cap
2.07BP/E (TTM)
11.82Basic EPS (TTM)
4.34Dividend Yield
0.04%Recent Filings
10-K
FY2025 results
Sylvamo's FY2025 net sales fell 11% y/y to $3.4B while net income dropped to $132M ($3.24 diluted EPS) from $302M ($7.18), with Adjusted EBITDA down to $448M (13% margin) from $632M (17%). Q4 momentum faltered amid lower uncoated freesheet volumes across all regions—Europe sales -7%, Latin America -7%, North America -14% (derived)—hit by maintenance outages and input costs, though North America gained pricing. Free cash flow slowed to $44M after $224M capex, yet $155M returned via $73M dividends and $82M buybacks. Debt stood at $842M floating (net of swaps), revolver with $333M available. 2026 signals North America transition via Riverdale exit and Eastover investments for efficiency. Cyclical paper demand threatens quarterly volumes.
8-K
Sylvamo Q4 earnings down
8-K
Adopts poison pill vs. Atlas
Sylvamo's board adopted a one-year shareholder rights plan on November 10, 2025, after Atlas Holdings ended a 2023 cooperation agreement by resigning its directors, freeing its 21.5% economic stake from standstill limits. Rights attach to common shares on November 20 and trigger at 15% beneficial ownership, diluting acquirers while letting current holders buy at a 50% discount. Board retains redemption flexibility. Protects long-term value.
10-Q
Q3 FY2025 results
Sylvamo's Q3 net sales fell 12% y/y to $846M from $965M, driven by lower North America uncoated paper volumes after International Paper's Georgetown mill closure, yet operating profit held at $98M (derived). Diluted EPS dropped to $1.41 from $2.27 on 40.3M shares, matching net income of $57M. North America carried the load at 53% of sales with $84M profit, while Europe swung to a $21M loss on price/mix weakness. Cash fell to $94M amid $174M YTD operating cash flow and $168M capex; long-term debt steady at $778M with $393M revolver availability. Share repurchases hit $82M YTD. Brazil tax disputes linger.
8-K
Q3 earnings surge
IPO
Website
Employees
Sector
Industry
CLW
Clearwater Paper Corporation
17.97+0.34
IP
International Paper Company
38.61+0.01
MAGN
Magnera Corporation
14.64+0.02
MATV
Mativ Holdings, Inc.
12.82+0.09
PKG
Packaging Corporation of Americ
203.66-0.82
RYAM
Rayonier Advanced Materials Inc
5.70-0.22
SFHG
Samfine Creation Holdings Group
0.75+0.07
SON
Sonoco Products Company
43.00+0.06
SUZ
Suzano S.A.
8.92-0.09
SVM
Silvercorp Metals Inc.
8.59+0.03